Is thioguanine-associated sinusoidal obstruction syndrome avoidable? Lessons learned from 6-thioguanine treatment of inflammatory bowel disease and a mouse model

Dirk P. van Asseldonk(Noordwest Ziekenhuisgroep), Timothy H. Florin(Translational Research Institute), Bindia Jharap(Meander Medisch Centrum), Iulia Oancea, John A. Duley(Griffith University)
Queensland's institutional digital repository (The University of Queensland)
March 1, 2012
Cited by 1

Related Papers

Mucin dynamics and enteric pathogens
|Nature Reviews Microbiology|2011|1.4k
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
|Nature Genetics|2011|1.4k
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice
|Gut|2019|221
Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
|Inflammatory Bowel Diseases|2010|199